All In Biotech

Drug Trial Radar · NCT03739203

The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

A Double-Blind, Placebo-Controlled Study of Cariprazine as an Adjunct to Antidepressants in the Treatment of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to Antidepressants Alone

Last checked: Nov 20, 2026Latest source record: Sep 21, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 752 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

752

Actual

Start

Nov 10, 2018

Primary completion

Sep 6, 2021

Study completion Sep 6, 2021

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Nov 13, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the efficacy, safety and tolerability of cariprazine as an adjunctive treatment to antidepressant therapy (ADT) in patients with MDD who have had an inadequate response to antidepressants alone.

Conditions

  • Major Depressive Disorder

Interventions

  • CariprazineDrug

    Cariprazine supplied in capsules

  • PlaceboDrug

    Placebo supplied in capsules

  • Antidepressant Therapy (ADT)Drug

    ADT as prescribed by the physician per standard of care in clinical practice.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Week 6 in the MADRS (Montgomery-Åsberg Depression Rating Scale) Total ScoreTime frame: Baseline and Week 6

Locations

112 sites in 8 countries. Site status is shown where the registry gives one.

  • Harmonex /ID# 236936

    Dothan, Alabama

  • Woodland International Research Group /ID# 236349

    Little Rock, Arkansas

  • California Pharmaceutical Research Institute /ID# 236731

    Anaheim, California

  • Axiom Research /ID# 236267

    Colton, California

  • Global Clinical Trials /ID# 235059

    Costa Mesa, California

  • Collaborative Neuroscience Research - Orange County /ID# 237637

    Garden Grove, California

  • Behavioral Research Specialists, LLC /ID# 236622

    Glendale, California

  • Sun Valley Research Center /ID# 236560

    Imperial, California

  • North County Clinical Research /ID# 235014

    Oceanside, California

  • Excell Research, Inc /ID# 237717

    Oceanside, California

  • NRC Research Institute /ID# 234632

    Orange, California

  • Anderson Clinical Research /ID# 236624

    Redlands, California

  • Syrentis Clinical Research /ID# 237408

    Santa Ana, California

  • California Neuroscience Research Medical Group, Inc. /ID# 236636

    Sherman Oaks, California

  • Schuster Medical Research Institute /ID# 236445

    Sherman Oaks, California

  • Pacific Clinical Research Management Group /ID# 234378

    Upland, California

  • MCB Clinical Research Centers /ID# 236927

    Colorado Springs, Colorado

  • CT Clinical Research /ID# 234638

    Cromwell, Connecticut

  • Innovative Clinical Research /ID# 235186

    Fort Lauderdale, Florida

  • Gulfcoast Clinical Research Center /ID# 236280

    Fort Myers, Florida

  • Innova Clinical Trials /ID# 237376

    Miami, Florida

  • International Research Associates, LLC /ID# 237410

    Miami, Florida

  • Medical Research Group of Central Florida /ID# 237326

    Orange City, Florida

  • Clinical Neuroscience Solutions, Inc /ID# 236604

    Orlando, Florida

  • Space Coast Neuropsychiatric Research Institute /ID# 235766

    Palm Bay, Florida

  • Atlanta Center for Medical Research /ID# 234696

    Atlanta, Georgia

  • Institute for Advanced Medical Research /ID# 234992

    Atlanta, Georgia

  • iResearch Savannah /ID# 236082

    Savannah, Georgia

  • Iris Research Inc. /ID# 234995

    Smyrna, Georgia

  • AMR Conventions Research /ID# 236262

    Naperville, Illinois

  • Collective Medical Research /ID# 236397

    Prairie Village, Kansas

  • Boston Clinical Trials /ID# 236558

    Boston, Massachusetts

  • BTC of New Bedford /ID# 236381

    New Bedford, Massachusetts

  • The Coastal Research Associates Inc /ID# 235056

    South Weymouth, Massachusetts

  • Sisu at Renaissance Medical Group /ID# 236198

    Springfield, Massachusetts

  • Center for Emotional Fitness /ID# 236630

    Cherry Hill, New Jersey

  • Bio Behavioral Health, Inc /ID# 238209

    Toms River, New Jersey

  • SPRI Clinical Trails /ID# 236657

    Brooklyn, New York

  • Bioscience Research /ID# 234961

    Mount Kisco, New York

  • Fieve Clinical Research, Inc. /ID# 236632

    New York, New York

Showing 40 of 112 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.